Research Article
Prognostic and Biological Significance of MicroRNA-127 Expression in Human Breast Cancer
Table 1
The correlations between miR-127 expression and clinicopathological factors of BC patients.
|
Factors | Relative miR-127 expression | P value | High () | Low () |
| Age (years) | | | 0.749 | 50 | 16 | 26 | | 50 | 28 | 40 | | Tumor size (cm) | | | 0.500 | 2.0 | 32 | 44 | | 2.0 | 12 | 22 | | Differentiation grade | | | 0.795 | G1 + 2 | 13 | 18 | | G3 | 31 | 48 | | Histological type | | | 0.352 | Ductal | 26 | 32 | | Lobular | 18 | 32 | | ER status | | | 0.936 | Negative | 17 | 26 | | Positive | 27 | 40 | | PR status | | | 0.340 | Negative | 20 | 24 | | Positive | 24 | 42 | | HER-2 status | | | 0.640 | Negative | 22 | 30 | | Positive | 22 | 36 | | Lymph node metastasis | | | | Absent | 26 | 25 | | Present | 18 | 41 | | Clinical stage | | | | I + II | 31 | 28 | | III | 13 | 38 | |
|
|
Statistically significant difference (P < 0.05). ER: estrogen receptor; PR: progesterone receptor; HER-2 c-erbB-2.
|